Legend Biotech (LEGN) is the lead sponsor of 6 active clinical trials listed on ClinicalTrials.gov[2], including 4 Phase 1[1].
LEGN has 1 Form 4 insider filing recorded at the SEC in the past 30 days[3].
LEGN is tracked by BiotechSigns with a current catalyst score of 15/100 and grade F. The page summarizes 0 active signals, including 0 PDUFA, 0 insider buying, and 0 clinical trial signals, with data refreshed on 2026-06-04.
Legend Biotech (LEGN) is the lead sponsor of 6 active clinical trials listed on ClinicalTrials.gov[2], including 4 Phase 1[1].
LEGN has 1 Form 4 insider filing recorded at the SEC in the past 30 days[3].